How Obesity Subtypes Predict Physical Function in Knee Osteoarthritis—and Why BMI Alone Isn’t Enough
Obesity is widely recognized as a major risk factor for knee osteoarthritis (OA), but not all individuals with obesity experience the same level of physical decline. Recent research from the Multicenter Osteoarthritis (MOST) Study reveals that obesity isn’t a one-size-fits-all condition—its subtypes, particularly variations in muscle mass and metabolic health, play a critical role in determining how well someone with knee OA can move and function.
If you’ve been told your obesity is contributing to joint pain, this study suggests that focusing solely on weight loss may overlook key factors influencing your mobility. Understanding these subtypes could help tailor interventions to slow functional decline and improve quality of life.
Beyond BMI: The Three Obesity Subtypes Linked to Knee OA Function
The study identified three distinct obesity subtypes, each associated with different patterns of physical function over time:
- Metabolically Healthy Obesity (MHO): Individuals with higher body fat but normal metabolic profiles (e.g., blood pressure, cholesterol, glucose levels). This group showed slower declines in physical function compared to other subtypes, suggesting metabolic health may partially offset the mechanical stress on joints.
- Metabolically Unhealthy Obesity (MUO): Those with obesity and metabolic dysfunction (e.g., insulin resistance, hypertension). This subtype exhibited the fastest functional decline, with accelerated loss of mobility and strength—likely due to combined mechanical joint stress and systemic inflammation.
- Muscle-Deficient Obesity (MDO): Individuals with obesity and low muscle mass (sarcopenic obesity). This group had intermediate declines but faced higher risks of falls and instability, as muscle weakness exacerbates joint instability.
These subtypes were determined using DXA scans (dual-energy X-ray absorptiometry) to measure body composition (fat vs. Muscle) alongside traditional BMI and metabolic markers.
Why Obesity Subtypes Matter More Than Weight Alone
Knee OA develops from a combination of mechanical stress (e.g., excess weight on joints) and biological factors (e.g., inflammation, cartilage breakdown). The study highlights three key mechanisms linking obesity subtypes to functional decline:
1. Mechanical Load vs. Muscle Support
While higher BMI increases joint stress, low muscle mass (MDO subtype) reduces the body’s ability to stabilize joints. Muscle acts as a natural shock absorber—when it’s diminished, even modest obesity can lead to faster cartilage degradation and pain.
Key stat: In the MOST Study, individuals with MDO lost 1.5x more physical function over 7 years compared to those with MHO, even when BMI was similar (source).
2. Metabolic Inflammation: The Silent Accelerator
The MUO subtype’s rapid functional decline isn’t just about weight—it’s about chronic low-grade inflammation (elevated CRP, cytokines) that damages joint tissues. Visceral fat, common in MUO, releases pro-inflammatory signals that worsen OA progression.
Expert insight: “Think of metabolic obesity as a ‘double hit’: Your joints bear extra mechanical load and your body’s immune system is in overdrive, attacking cartilage,” explains Dr. Emily Splinter, rheumatologist and study co-author.
3. The Muscle-Obese Paradox
Surprisingly, the MHO group had better outcomes than expected. Researchers theorize that higher muscle mass in metabolically healthy individuals may compensate for some joint stress, while their normal metabolic profiles reduce systemic inflammation.
What This Means for Diagnosis and Treatment
Current OA guidelines often focus on weight loss as the primary intervention. However, this study suggests a more nuanced approach:
- For MUO: Prioritize metabolic interventions (e.g., anti-inflammatory diets, medications like GLP-1 agonists) alongside joint protection strategies. A 2025 meta-analysis in JAMA Network Open found that metabolic improvements reduced OA progression by 30% even without significant weight loss (source).
- For MDO: Resistance training is critical. A 2026 study in Arthritis & Rheumatology showed that leg-strengthening programs slowed functional decline by 40% in sarcopenic obesity patients (source).
- For MHO: Focus on maintaining metabolic health (e.g., regular cardio, balanced nutrition) to preserve joint function. These individuals may benefit most from low-impact exercise (e.g., swimming, cycling) to reduce joint stress without triggering inflammation.
“BMI alone can’t predict who will struggle most with knee OA,” says Dr. Singh. “A DXA scan or even simple grip strength tests in clinic could help identify high-risk subtypes early.”
FAQ: Obesity Subtypes and Knee OA
1. Can I tell my obesity subtype without a DXA scan?
Not definitively, but red flags for MUO include:
- High blood pressure or cholesterol
- Prediabetes or insulin resistance
- Central obesity (fat around the abdomen)
MDO may present with:
- Weakness in legs/arms
- Difficulty climbing stairs
- Slower walking speed
Talk to your doctor about a body composition assessment if you’re concerned.
2. Does this mean weight loss isn’t important?
No—weight loss still helps, but the study shows it’s not the only factor. Even modest weight loss (5–10%) can reduce knee joint stress by up to 30%, but combining it with metabolic or muscle-focused interventions yields better results.
3. Are there supplements or foods that help?
For MUO, focus on anti-inflammatory foods (e.g., omega-3s, turmeric, leafy greens) and consider supplements like collagen peptides (shown to improve joint pain in some studies). For MDO, protein-rich foods and vitamin D support muscle health.
Key Takeaways for Patients and Providers
- Obesity isn’t uniform: Your subtype (MHO, MUO, or MDO) may determine how knee OA affects you.
- Muscle matters: Low muscle mass (MDO) accelerates functional decline more than fat alone.
- Metabolic health is critical: MUO drives faster OA progression due to inflammation.
- Personalized interventions work best: Weight loss + metabolic management (MUO) or strength training (MDO) may be more effective than weight loss alone.
- Early screening helps: Ask your doctor about body composition testing if you have obesity and knee pain.
What’s Next for Research and Treatment
Ongoing studies are exploring:
- Biomarkers: Blood tests to identify MUO or MDO before symptoms worsen.
- Targeted therapies: Drugs like SGLT2 inhibitors (used for diabetes) showing promise in reducing OA inflammation.
- Digital tools: Wearables to track muscle function and metabolic health in real time.
“The future of OA care may lie in precision medicine—matching treatments to an individual’s obesity subtype rather than treating everyone the same,” says Dr. Singh.